Company Short-Term Debts: Absci Corporation (ABSI)

Graphic logo of Absci Bio (ABSI)

Absci combines artificial intelligence capabilities with biology to design antibodies, integrating its developments into the laboratories of the largest pharmaceutical behemoths. The asset's market value, clearly illustrated on this chart, is accompanied by the current metric 0.00. Long-term generative AI contracts provide the company with stability while results for its own molecules are awaited. The business relies on the digitalization of medicine and the optimization of healthcare data management.

absci.com (ABSI) Company Short-Term Indebtedness: for the period 07/04/2022 - 10/28/2026

Absci Bio - analytical breakdowns and key metrics (ABSI)

- price and consensus price forecast:
Price Chart Absci Corporation|ABSI - Consensus Target
- market capitalization data:
Market Capitalization Absci Corporation|ABSI - Total Enterprise Value
- book capitalization data:
Book Value per Share Absci|ABSI - Accounting Capitalization|Market Capitalization to Book Value Ratio absci.com|ABSI - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Absci|ABSI - Long-Term Debt to Equity|Short-Term Debt to Equity Absci|ABSI - Company Total Debt Obligations|Debts to Book Capitalization Absci Corporation|ABSI - Company Long-Term Liabilities|Company Short-Term Debts Absci
Analysis of all company metrics:Absci Corporation - ABSI
Mass-produced product of Absci

This indicator measures the total volume of financial liabilities for Absci (ABSI) with a maturity of up to one year. Monitoring short-term liabilities allows for an assessment of liquidity and the risk of cash flow gaps. For an AI antibody developer, such a metric reflects the balance between debt capital and R&D expenditures. A reduction in the debt load confirms financial stability. A stable level of debt guarantees protection against default while maintaining the pace of technological leadership.

Competitors of Absci (ABSI)

VEEV: Company Short-Term Debt|DOCS - Company Current Liabilities|Company Short-Term Debts HQY|Waystar Corp (WAY) - Short-Term Debt|Company Short-Term Debts CorVel Corporation (CRVL)|Company Short-Term Indebtedness priviahealth.com|Company Short-Term Debts HURN|Company Short-Term Debts Certara Inc (CERT)|Company Short-Term Debts Omnicell Corp OMCL|GoodRx Gold - Company Short-Term Debt|Company Short-Term Debt SDGR (Schrodinger, Inc.)|PHR - Short-Term Debt Volume|OMDA (Omada Health) - Company Short-Term Debts|Evolent Health Inc (EVH) - Company Current Liabilities|HSTM: Company Short-Term Debts|Short-Term Debt Volume Definitive Corp|Company Short-Term Debts CCSI|Company Short-Term Debts agilonhealth.com (AGL)|Company Short-Term Debts So-Young International Inc. SY|NRC Health Inc. - Company Short-Term Debt|Company Short-Term Debt SPOK (Spok Corp)|OPRX - Short-Term Debt Volume|TruBridge, Inc. - Company Short-Term Debts|simulations-plus.com (SLP) - Short-Term Debt Volume|SOPH: Company Short-Term Debts|Short-Term Debt Volume Health Catalyst Inc. (HCAT)|Company Current Liabilities CareCloud, Inc.|Amount of Current Liabilities researchsolutions.com RSSS|Company Current Liabilities DLH Holdings|OneMedNet Corp - Company Short-Term Loans and Borrowings|SCNX: Company Short-Term Debt|HCTI - Company Current Liabilities|Company Short-Term Debts ISPC|Bullfrog AI (BFRG) - Short-Term Debt|Company Short-Term Debts SCWorx Corp. (WORX)|Company Short-Term Indebtedness msprecovery.com|Company Short-Term Debts ICCT|Company Short-Term Debts TRxADE HEALTH Inc (MEDS)|Company Short-Term Debts Orgenesis Corp ORGS|R1 RCM, Inc. - Company Short-Term Debt|Company Short-Term Debt SHCR (Sharecare, Inc.)|STRM - Short-Term Debt Volume|SYRA (Syra Health) - Company Short-Term Debts|Apollo Medical Holdings, Inc. (AMEH) - Company Current Liabilities|MODN: Company Short-Term Debts|Short-Term Debt Volume NextGen Healthcare Corp